A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it’s 2021, are we there yet?
In this report, we present a 29-year-old African American female who was brought to a local emergency department after being found unresponsive by her mother. The etiology of her stroke and severe hemolysis remained unknown, despite her mother reporting the patient’s history of co-inheritance of sic...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-09-01
|
Series: | Journal of Community Hospital Internal Medicine Perspectives |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20009666.2021.1954285 |
id |
doaj-65b5a5d6f57c419383d150dbcf9b5816 |
---|---|
record_format |
Article |
spelling |
doaj-65b5a5d6f57c419383d150dbcf9b58162021-10-04T13:57:01ZengTaylor & Francis GroupJournal of Community Hospital Internal Medicine Perspectives2000-96662021-09-0111571371810.1080/20009666.2021.19542851954285A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it’s 2021, are we there yet?Ava Runge0Danielle Brazel1Zahra Pakbaz2University of California Irvine Medical CenterUniversity of California Irvine Medical CenterUniversity of California Irvine Medical CenterIn this report, we present a 29-year-old African American female who was brought to a local emergency department after being found unresponsive by her mother. The etiology of her stroke and severe hemolysis remained unknown, despite her mother reporting the patient’s history of co-inheritance of sickle cell trait and beta-thalassemia trait, and extensive workup during her prolonged hospitalization. She was diagnosed with sickle cell disease (Sβ+ type) two years after discharge when she was referred to a sickle cell specialist for persistent anemia. Here, we also briefly review the challenges to diagnose rarer subtypes of sickle cell disease (SCD), in this case Sβ+ type, as well as the pathophysiology and current management of stroke in SCD.http://dx.doi.org/10.1080/20009666.2021.1954285sickle cell diseasesickle cell beta-plus thalassemiacompound heterozygousstroke |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ava Runge Danielle Brazel Zahra Pakbaz |
spellingShingle |
Ava Runge Danielle Brazel Zahra Pakbaz A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it’s 2021, are we there yet? Journal of Community Hospital Internal Medicine Perspectives sickle cell disease sickle cell beta-plus thalassemia compound heterozygous stroke |
author_facet |
Ava Runge Danielle Brazel Zahra Pakbaz |
author_sort |
Ava Runge |
title |
A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it’s 2021, are we there yet? |
title_short |
A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it’s 2021, are we there yet? |
title_full |
A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it’s 2021, are we there yet? |
title_fullStr |
A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it’s 2021, are we there yet? |
title_full_unstemmed |
A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it’s 2021, are we there yet? |
title_sort |
case of sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it’s 2021, are we there yet? |
publisher |
Taylor & Francis Group |
series |
Journal of Community Hospital Internal Medicine Perspectives |
issn |
2000-9666 |
publishDate |
2021-09-01 |
description |
In this report, we present a 29-year-old African American female who was brought to a local emergency department after being found unresponsive by her mother. The etiology of her stroke and severe hemolysis remained unknown, despite her mother reporting the patient’s history of co-inheritance of sickle cell trait and beta-thalassemia trait, and extensive workup during her prolonged hospitalization. She was diagnosed with sickle cell disease (Sβ+ type) two years after discharge when she was referred to a sickle cell specialist for persistent anemia. Here, we also briefly review the challenges to diagnose rarer subtypes of sickle cell disease (SCD), in this case Sβ+ type, as well as the pathophysiology and current management of stroke in SCD. |
topic |
sickle cell disease sickle cell beta-plus thalassemia compound heterozygous stroke |
url |
http://dx.doi.org/10.1080/20009666.2021.1954285 |
work_keys_str_mv |
AT avarunge acaseofsbsicklecelldiseasediagnosedinadulthoodfollowingacutestrokeits2021arewethereyet AT daniellebrazel acaseofsbsicklecelldiseasediagnosedinadulthoodfollowingacutestrokeits2021arewethereyet AT zahrapakbaz acaseofsbsicklecelldiseasediagnosedinadulthoodfollowingacutestrokeits2021arewethereyet AT avarunge caseofsbsicklecelldiseasediagnosedinadulthoodfollowingacutestrokeits2021arewethereyet AT daniellebrazel caseofsbsicklecelldiseasediagnosedinadulthoodfollowingacutestrokeits2021arewethereyet AT zahrapakbaz caseofsbsicklecelldiseasediagnosedinadulthoodfollowingacutestrokeits2021arewethereyet |
_version_ |
1716843968128352256 |